Morphine and anandamide coupling to nitric oxide stimulates, GnRH and CRF release from rat median eminence: Neurovascular regulation

Brain Research

Volumn 790, Issue 1-2, 1998, Pages 236-244

  Prevot, Vincent ^a   Rialas, Christos M ^b   Croix, Dominique ^a   Salzet, Michel ^c   Dupouy, Jean Paul ^c   Poulain, Pierre ^a   Beauvillain, Jean Claude ^a   Stefano, George B ^b  

^a INSERM   (France)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIV LILLE   (France)

Author keywords

Cannabinoid receptor; CRH; GnRH; Hypothalamus; Median eminence; Nitric oxide; Opiate receptor; Opioid

Indexed keywords

CANNABINOID RECEPTOR; CORTICOTROPIN RELEASING FACTOR; GONADORELIN; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG RECEPTOR BINDING; HORMONAL REGULATION; HORMONE RELEASE; MALE; MEDIAN EMINENCE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CORTICOTROPIN-RELEASING HORMONE; ENKEPHALIN, METHIONINE; ENZYME INHIBITORS; GONADOTROPIN-RELEASING HORMONE; MALE; MEDIAN EMINENCE; MORPHINE; NARCOTICS; NEUROSECRETORY SYSTEMS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; VASOMOTOR SYSTEM;

EID: 0032550202     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00066-3     Document Type: Article

References (60)

1. K. Aguan, V.B. Malesh, L. Ping, G. Bhat, D.W. Brann, Evidence for physiological role for nitric oxide in the regulation of the LH surge: effect of central administration of antisense oligonucleotides to nitric oxide synthase, Neuroendocrinology 64 (1996) 449-455.
2. B.L. Barry, M.P. Dubois, P. Poulain, Immunofluorescence study of the preopticoinfundibular LRF neurosecretory pathway in the normal, castrated, or testosterone treated male guinea pig, Endocrinology 133 (1974) 1911-1914.
3. B.M. Bayer, C.M. Flores, Effects of morphine on lymphocyte function: possible mechanisms of interaction, in: R.R. Watson (Ed.), Drugs of Abuse and Immune Function, CRC Press, Boca Raton, FL, 1990, pp. 151-174.
4. E. Bianchi, C. Alessandrini, M. Guarna, A. Tagliamonte, Endogenous codeine and morphine are stored in specific brain neurons, Brain Res. 627 (1993) 210-215.
5. E. Bianchi, M. Guarna, A. Tagliamonte, Immunocytochemical localization of endogenous codeine and morphine, Adv. Neuroimmunol. 4 (1994) 83-92.
6. J.J. Bonavera, A. Sahu, P.S. Kalra, S.P. Kalra, Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids, Endocrinology 133 (1993) 2481-2487.
7. T.V. Bilfinger, A. Hartman, Y. Liu, H.I. Magazine, G.B. Stefano, Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure, Ann. Thor. Surgery 63 (1997) 1063-1069.
8. W. Brann, G.K. Bhat, C.A. Lamar, V.B. Malesh, Gaseous transmitters and neuroendocrine regulation, Neuroendocrinology 65 (1997) 385-395.
9. S. Bredt, P.M. Hwang, S.H. Snyder, Localization of nitric oxide synthase indicating a neural role for nitric oxide, Nature 347 (1990) 768-770.
10. H.U. Bryant, B.B. Yoburn, C.E. Inturrisi, E.W. Bernton, J.W. Holaday, Morphine-induced immunosuppression is not related to serum morphine concentrations, Eur. J. Pharmacol. 149 (1988) 165.
11. J.C. Buckingham, Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides, Neuroendocrinology 35 (1982) 111-116.
12. S. Ceccatelli, J.M. Lundberg, D.S. Fahrenkrug, D.S. Bredt, S.H. Snyder, T. Hökfelt, Evidence for involvement of nitric oxide in the regulation of hypothalamic portal blood flow, Neuroscience 51 (1992) 769-772.
13. M. Ching, Morphine suppresses the proestrous surge of GnRH in pituitary portal plasma of rats, Endocrinology 112 (1983) 2209-2211.
14. A. Costa, P. Trainer, M. Besser, A. Grossman, Nitric oxide modulates the release of corticotrophin-releasing hormone from the rat hypothalamus in vitro, Brain Res. 2 (1993) 187-192.
15. G. Deutsch, M.S. Goligorsky, P.C. Schmid, R.J. Krebsbach, H.H.O. Schmid, S.K. Das, S.K. Dey, G. Arreaza, Thorup, G.B. Stefano, L.C. Moore, Production and physiological actions of anandamide in the vasculature of the rat kidney, J. Clin. Invest. 100 (1997) 1538-1546.
16. M.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, A. Mandelbaum, A. Etinger, R. Mechoulam, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258 (1992) 1946-1949.
17. R.M. Eisenberg, Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists, J. Pharmacol. Exp. Ther. 233 (1985) 863-869.
18. U. Forstermann, H. Kleinert, Nitric oxide synthase: expression and expressional control of the three isoforms, Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 351-364.
19. A. Goldstein, R.W. Barrett, I.F. James, L.I. Lowney, C. Weitz, L.L. Knipmeyer, H. Rapoport, Morphine and other opiates from beef brain and adrenal, Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 5203-5207.
20. E. Herbison, S.X. Simonian, P.J. Norris, P.C. Emson, Relationship of neuronal nitric oxide synthase immunoreactivity to GnRH neurons in the ovariectomized and intact female rat, J. Neuroendocrinol. 8 (1996) 73-82.
21. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, K.C. Rice, Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J. Neurosci. 11 (1991) 563-583.
22. M. Herkenham, A.B. Lynn, L.S. Melvin, B.R. de Costa, E.K. Richfield, Neuronal localization of cannabinoid receptors in the basal ganglia of the rat, Brain Res. 547 (1991) 267-274.
23. W.M. Hunter, F.C. Greenwood, Preparation of iodine-131 labelled human growth hormone of high specific activity, Nature 194 (1962) 495-496.
24. T. Ieiri, H.T. Chen, G.A. Campbell, J. Mietes, Effects of naloxone and morphine on the proestrus surge of prolactin and gonadotropins in the rat, Endocrinology 106 (1980) 1568.
25. A.L. Jackson, L.L. Murphy, Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol, Neuroendocrinology 65 (1997) 446-452.
26. S.P. Kalra, T. Horvath, F. Naftolin, B. Xu, S. Pu, P.S. Kalra, The interactive language of the hypothalamus for the gonadotropin releasing hormone (GNRH) system, J. Neuroendocrinol. 9 (1997) 569-576.
27. S. Karanth, K. Lyson, S. McCann, Role of nitric oxide in interleukin 2-induced corticotrophin-releasing factor release from incubated hypothalami, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3383-3387.
28. Y. Liu, D. Shenouda, T.V. Bilfinger, M.L. Stefano, H.I. Magazine, G.B. Stefano, Morphine stimulates nitric oxide release from invertebrate microglia, Brain Res. 722 (1996) 125-131.
29. F.J. Lopez, M. Moretto, I. Merchentaler, A. Negro-Vilar, Nitric oxide is involved in the genesis of pulsatile LHRH secretion from immortalized LHRH neurons, J. Neuroendocrinol. 9 (1997) 647-654.
30. H.I. Magazine, Detection of endothelial cell-derived nitric oxide: current trends and future directions, Adv. Neuroimmunol. 5 (1995) 479.
31. H.I. Magazine, Y. Liu, T.V. Bilfinger, G.L. Fricchione, G.B. Stefano, Morphine-induced conformational changes in immunocytes, endothelial cells and microglia are mediated by nitric oxide, J. Immunol. 156 (1996) 4845-4850.
32. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, T.I. Bonner, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature 346 (1990) 561-564.
33. M. Moretto, F.J. Lopez, A. Negro-Villar, Nitric oxide regulates luteinizing hormone releasing hormone secretion, Endocrinology 133 (1993) 2399-2402.
34. S. Munro, K.L. Thomas, M. Abu-Shaar, Molecular characterization of a peripheral receptor for cannabinoids, Nature 365 (1993) 61-65.
35. T.M. Nett, T.E. Adams, Further studies on the radioimmunoassay of gonadotropin releasing hormone. Effect of radioiodination, antiserum and unextracted serum on levels of immunoreactivity in serum, Endocrinology 101 (1977) 1135-1144.
36. K.E. Nikolarakis, A. Pfeiffer, G. Stalla, A. Herz, The role of CRF in the release of ACTH by opiate agonists and antagonists in rats, Brain Res. 421 (1987) 373-376.
37. K.E. Nikolarakis, A. Pfeiffer, G. Stalla, A. Herz, Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways, Brain Res. 498 (1989) 385-388.
38. S. Pu, T.L. Horvath, S. Diano, F. Naftolin, P.S. Kalra, S.P. Kalra, Evidence showing that β-endorphin regulates cyclic guanosine 3′,5′-monophosphate (cGMP) efflux: anatomical and functional support for an interaction between opiates and nitric oxide, Endocrinology 138 (1997) 1537-1543.
39. C.N. Pang, E. Zimmermann, C.H. Sawyer, Morphine inhibition of the preovulatory surges of plasma luteinizing hormone and follicle stimulating hormone in rat, Endocrinology 101 (1977) 1726-1732.
40. J. Raber, G.F. Koob, F.E. Bloom, Interleukin-2 (IL-2) induces corticotrophin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response, J. Pharmacol. Exp. Ther. 272 (1995) 815-824.
41. V. Rettori, N. Belova, W.L. Dees, C.L. Nyberg, M. Gimeno, S.M. McCann, Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10130-10134.
42. E.M. Smith, T.K. Hughes, F. Hashemi, G.B. Stefano, Immunosuppressive effects of ACTH and MSH and their possible significance in human immunodeficiency virus infection, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 782-786.
43. G.B. Stefano, Autoimmunovascular regulation: morphine-stimulated nitric oxide release, J. Neuroimmunol., 1998, in press.
44. G.B. Stefano, V.B. Christensen, E. Tonnesen, Y. Liu, T.K. Hughes, T.V. Bilfinger, Interleukin 10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence, J. Cardiovasc. Pharmacol. 30 (1997) 90-95.
45. G.B. Stefano, A. Digenis, S. Spector, M.K. Leug, T.V. Bilfinger, M.H. Makman, B. Scharrer, N.N. Abumrad, Opiate-like substances in an invertebrate, and opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11099-11103.
46. 3 opiate receptor in endothelial cells, J. Biol. Chem. 270 (1995) 30290-30293.
47. G.B. Stefano, Y. Liu, M.S. Goligorsky, Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia and human monocytes, J. Biol. Chem. 271 (1996) 19238-19242.
48. G.B. Stefano, M. Salzet, H.I. Magazine, T.V. Bilfinger, Antagonist of LPS and IFN-g induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase, J. Cardiovasc. Pharmacol., 1998, in press.
49. G.B. Stefano, B. Salzet, C.M. Rialas, M. Pope, A. Kustka, K. Neenan, P. Pryor, M. Salzet, Morphine and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release, Brain Res. 763 (1997) 63-68.
50. G.B. Stefano, B. Scharrer, Endogenous morphine and related opiates, a new class of chemical messengers, Adv. Neuroimmunol. 4 (1994) 57-68.
51. G.B. Stefano, E.M. Smith, Adrenocorticotropin - a central trigger in immune responsiveness: tonal inhibition of immune activation, Med. Hypotheses 46 (1996) 471-478.
52. G. Tramu, D. Croix, A. Pillez, Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin-like material. Immunohistochemical demonstration in adrenalectomized guinea pigs and rats, Neuroendocrinology 37 (1983) 467-469.
53. H. Tsukahara, D.V. Gordienko, M.S. Goligorsky, Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells, Biochem. Biophys. Res. Commun. 193 (1993) 722.
54. F. Vallebuona, M. Raiteri, Extracellular cGMP in the hippocampus of freely moving rats as index of nitric oxide (NO) synthase activity, J. Neurosci. 14 (1994) 134-139.
55. J. Weidenfeld, S. Feldman, R. Mechoulam, Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamic-pituitary-adrenal axis in the rat, Neuroendocrinology 59 (1994) 110-112.
56. J. Weitz, L.I. Lowney, K.F. Faull, G. Feister, A. Goldstein, Morphine and codeine from mammalian brain, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 9784-9788.
57. T. Wenger, K.A. Jamali, C. Juaneda, J. Leonardelli, G. Tramu, Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus, Biochem. Biophys. Res. Commun. 237 (1997) 724-728.
58. T. Wenger, V. Rettotri, G.D. Snyder, S. Dalterio, S.M. McCann, Effect of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle-stimulating hormone secretion in adult male rats, Neuroendocrinology 46 (1987) 488-493.
59. K. Yamada, P. Emson, T. Hökfelt, Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides, J. Chem. Neuroanat. 10 (1996) 295-331.
60. E. Zimmerman, C.N. Pang, Acute effects of opiate administration on pituitary gonadotropin and prolactin release, in: D.H. Ford, D.H. Clouet (Eds.), Tissue Responses to Addictive Drugs, Spectrum Publ., New York, 1976, p. 517.